CIZA -MPS
Brand:
CIZA -MPS
Manufacturer:
INTAS
Manufacturer Details
INTAS
Compositions:
Cisapride monohydrate 10mg,
Methyl ploysiloxane 125mg tabs,
|
Strength
|
Rate
|
Packing Style
|
|
10mg
|
0.00
|
Tab
|
List of Related Indications:
- Gastroestrophageal reflux disease (GERD)
List Of Drugs:
- Cisapride + Simethicone -(FDC-List)
Indication Type Description:
Drug Interaction:
Not available
Indication:
Gastro-oseophageal disease
Dyspepsia
Cisapride
Fluoroquinolones include the following :
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Cisapride Gastrointestinal disorders November 1992
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
Cisapride + 03-05-1993
M.P.S chewable tablet
Management of dyspepsia due to functional causes, peptic ulcer
and osesophagitis, prevention and therapy of reflux osesophagitis.
gastroporosis, due to diabetic neurophatic , anorexia, nausea,
vogotomy, post operative causes, radition therapy, gastritis,
intestinal psends obstructive uremia ulcerative and non ulcerative
dyspepsia, restoration of intestinal motility in chronic constipation
Adverse Reaction:
Not available
Contra-Indications:
Not available
Dosages/ Overdosage Etc:
Indication-
Gastro-oseophageal disease
Dyspepsia
Dosage-
Adult- Cisapride 5-10mg 3-4 times daily
